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Abstract
Transplantation of neural stem/progenitor cells (NS/PCs) following the sub-acute phase of spinal cord injury (SCI) has been
shown to promote functional recovery in rodent models. However, the types of cells most effective for treating SCI have not
been clarified. Taking advantage of our recently established neurosphere-based culture system of ES cell-derived NS/PCs, in
which primary neurospheres (PNS) and passaged secondary neurospheres (SNS) exhibit neurogenic and gliogenic
potentials, respectively, here we examined the distinct effects of transplanting neurogenic and gliogenic NS/PCs on the
functional recovery of a mouse model of SCI. ES cell-derived PNS and SNS transplanted 9 days after contusive injury at the
Th10 level exhibited neurogenic and gliogenic differentiation tendencies, respectively, similar to those seen in vitro.
Interestingly, transplantation of the gliogenic SNS, but not the neurogenic PNS, promoted axonal growth, remyelination,
and angiogenesis, and resulted in significant locomotor functional recovery after SCI. These findings suggest that gliogenic
NS/PCs are effective for promoting the recovery from SCI, and provide essential insight into the mechanisms through which
cellular transplantation leads to functional improvement after SCI.
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Introduction
Because the adult central nervous system (CNS) has limited
potential for regeneration, spinal cord injury (SCI) results in severe
dysfunction, such as paraplegia and tetraplegia. With the aim of
regenerating the injured spinal cord, various intraspinal cellular
transplants have been investigated, especially in the sub-acute
phase after injury. This period, between the acute and chronic
phases, is marked by the minimal expression of cytokines, and is
likely to be amenable to transplantation therapy [1,2,3,4,5].
Embryonic stem (ES) cells, with their indefinite replication
potential, pluripotency, and genetic flexibility, have attracted
great interest, and methods for inducing their neural differentia-
tion have been extensively studied [6]. ES cell-derived neural
progenitors are currently one of the most promising cell sources for
cell transplantation therapy for treating SCI. Although previous
studies demonstrated that the transplantation of mouse ES cell-
derived embryoid bodies [7] or human ES cell-derived oligoden-
drocyte progenitor cells [8] promotes overall functional recovery
after SCI, the types of neural progenitor cells most effective for
treating sub-acute phase SCI has been uncertain.
We recently reported that a low concentration of retinoic acid
(10
28 M: low-RA) can efficiently induce caudalized neural
progenitors in embryoid bodies (EBs) [9], and we established a
neurosphere-based culture system of ES cell-derived neural stem/
progenitor cells (NS/PCs) from low-RA-treated EBs, with
midbrain to hindbrain identities [10]. These ES cell-derived
primary neurospheres (PNS) mainly exhibit neurogenic differen-
tiation potentials, whereas passaged secondary neurospheres (SNS)
are more gliogenic, corresponding to changes in CNS develop-
ment, in which neurogenic NS/PCs predominate early in
gestation and gliogenic NS/PCs predominate in mid-to-late
gestation. Here, taking advantage of this difference between
neurogenic PNS and gliogenic SNS, we transplanted PNS and
SNS into the injured spinal cord, examined the differentiation and
growth properties of the grafted cells, and compared their effects
on angiogenesis, axonal regeneration, and functional recovery
after SCI. We also examined the survival and growth of the
PLoS ONE | www.plosone.org 1 November 2009 | Volume 4 | Issue 11 | e7706transplanted ES cell-derived NS/PCs using in vivo, live, biolumi-
nescent imaging (BLI) to evaluate the tumorigenicity and safety of
the grafted cells.
Results
Establishment of a Stable ES Cell Line Expressing CBRluc
Luminescence and Venus Fluorescence
We first established an ES cell line that constitutively expresses
the click beetle red-emitting luciferase (CBRluc) [11] and Venus
[12] by introducing a CAG-CBRluc-IRES-Venus plasmid (Fig. 1A)
into EB3 ES cells (CCV-ES cells) [13]. CCV-ES cells and their
progenies were detected by both BLI [3,14,15] and fluorescence
microscopy. To induce NS/PCs from ES cells and obtain PNS
and SNS, we used a neurosphere-based culture system that we
recently reported [10] (Fig. 1B), as described in Materials and
Methods. More than 99% of the undifferentiated CCV-ES cells
expressed Venus fluorescence by flow cytometry (Fig. 1D and E),
and CCV-ES cell-derived PNS (CCV-PNS) and SNS (CCV-SNS)
showed steady fluorescence that was detectable by fluorescence
microscopy (Fig. 1C). Approximately 80% of the cells in the CCV-
PNS and -SNS were positive for Venus by flow cytometry (Fig. 1D
and E). bioluminescence imaging (BLI) revealed CBRluc expres-
sion in both CCV-PNS and –SNS, and we confirmed that the
photon counts were in direct proportion to the cell numbers in vitro
(Fig. 1F). We also confirmed that the CCV-ES cells could generate
PNS and SNS similar to EB3-ES cells (Fig. 1C).
Distinct Differentiation Potentials of PNS and SNS In Vitro
We next examined the in vitro differentiation potentials of the
PNS and SNS derived from EB3- and CCV-ES cells. PNS and
SNS derived from EB3- and CCV-ES cells were allowed to
differentiate in medium without FGF2 on poly-L-ornithine/
fibronectin coated coverslips for 5 days, and then processed for
immunocytochemistry. We examined the frequency of colonies
consisting of bIII tubulin-positive neurons, GFAP-positive astro-
cytes, and/or O4-positive oligodendrocytes, and found that the
EB3- and CCV-PNS colonies predominantly differentiated into
neurons, although a small number of colonies contained both
neurons and glia (Fig. 1G). In contrast, most of the EB3- and
CCV-SNS colonies differentiated into both neurons and glia,
including astrocytes and oligodendrocytes, or into only glial cells
(Fig. 1G), demonstrating that the ES cell-derived PNS and SNS
had distinct differentiation potentials in vitro (Fig. 1H). Moreover,
EB3- and CCV-ES cell-derived neurospheres exhibited similar
differentiation properties, confirming that the transgene in the ES
cells had negligible effects on differentiation (Fig. 1H).
We also examined the SNS formation rates to determine the
self-renewing ability of the ES cell-derived PNS. We cultured
CCV-PNS at a low cell density (2.5610
4 cells/ml), transferred
them into 96-well plates at one neurosphere/well, dissociated the
neurospheres, and cultured them again with FGF2 to form
secondary neurospheres. Most of the CCV-PNS generated
secondary neurospheres (79/90; 87.7%; from more than three
independent experiments), confirming their ability to self-renew.
Transplanted SNS Prevented Atrophic Change and
Demyelination after SCI
A contusive SCI was induced at the Th10 level of C57BL6
mice, and 5610
5 cells of CCV-PNS or CCV-SNS, or PBS as a
control, were injected into the lesion epicenter 9 days after injury.
We refer to these, respectively, as the PNS, SNS, and control
groups. After 6 weeks, histological analyses were performed. We
first examined atrophic changes of the injured spinal cord by
Hematoxylin-eosin (H–E) staining (Fig. 2A and B). The transverse
area of the spinal cord at the lesion epicenter was significantly
larger in the SNS group than in the control group, suggesting that
SNS transplantation prevented atrophy of the injured spinal cord
(Fig. 2E). Luxol Fast Blue (LFB) staining revealed significantly
greater preservation of the myelinated areas in the SNS group
compared with the control (both 2 and 6 weeks after injury) and
PNS groups (Fig. 2C and D), from 1 mm rostral to 1 mm caudal
to the epicenter (Fig. 2F). Notably, there was a significantly spared
rim of white matter in the SNS group, even at the lesion epicenter,
whereas the control group exhibited severely demyelinated white
matter throughout the lesioned area (2 mm rostral and caudal to
the lesion epicenter) (Fig. 2C and D).
Transplanted PNS and SNS survived in the injured spinal
cord and did not form tumors
The photon count measured by bioluminescence imaging (BLI)
quantifies only living cells, since the luciferin-CBR-luciferase
reaction depends on oxygen and ATP. The successful transplan-
tation of CCV-PNS and -SNS was confirmed immediately after
transplantation using BLI, and the average signal intensity was
2.261.6610
5 photons/mouse/sec in 22 transplanted mice.
Images obtained weekly thereafter for 6 weeks showed that the
signal intensity dropped sharply within the first week after
transplantation, but remained at 20% of the initial photon count
in both the PNS and SNS transplantation groups throughout the
remaining period. Although the signal intensity at 1 week was
significantly higher in the PNS group (62.4%) than in the SNS
group (29.5%), there was no significant difference in the signal
intensity between the PNS (12.6%) and SNS (18.9%) groups at 6
weeks, suggesting there was a similar number of live grafted PNS-
and SNS-derived cells within the injured spinal cord 6 weeks after
transplantation. Thus, similar numbers of grafted PNS and SNS
cells may have survived in the injured spinal cord, although the
possibility that the grafted cells proliferated differently in the two
groups 1 to 6 weeks after transplantation cannot be excluded.
Notably, a rapid increase in signal intensity, which would have
suggested tumor formation, was not observed during this time
period (Fig. 3Aa n dB ). Consistently, histological analysis
confirmed that both the CCV-PNS- and CCV-SNS-derived
Venus-positive cells survived without forming tumors (Fig. 3C–F).
Quantitative analysis of the Venus-positive area revealed that
there was no significant difference of the number of survived
grafted cells between PNS and SNS groups 6 weeks after
transplantation (Fig. 3G). Moreover, the data of BLI correlated
well with Venus-positive area (Pearson’s correlation coefficient:
0.759, p=0.04, Fig. 3H).
PNS and SNS Grafted onto Injured Spinal Cord Exhibited
Differentiation Potentials Similar to Those Observed In
Vitro
To examine the differentiation characteristics of CCV-PNS and
-SNS grafted onto the injured spinal cord, we performed
immunohistochemical analyses, and determined the proportion
of cells immunopositive for each cell type-specific marker among
the Venus-positive grafted cells [3]. Both the PNS- and SNS-
derived cells integrated at or near the lesion epicenter and
differentiated into Hu-positive neurons, GFAP-positive astrocytes,
and APC-positive oligodendrocytes (Fig. 4A–E). The percentage of
Hu/Venus double-positive neurons in the PNS group
(52.8619.1%) was three times that in the SNS group
(16.365.2%) (Fig. 4F). In contrast, the percentage of GFAP/
Venus double-positive astrocytes or APC/Venus double-positive
ES Cell-Derived NS/PCs
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twice that in the PNS group (19.069.3, 14.867.1%) (Fig. 4F)
(n=4). The differentiation patterns of the grafted PNS and SNS
were consistent with the results of the in vitro differentiation assay,
suggesting that PNS and SNS preserved their differentiation
tendencies in vivo.
Figure 1. Establishment of a stable ES cell line expressing CBRluc luminescence and Venus fluorescence, and their differentiation
analysis. (A) The CAG-CBRluc–IRES-Venus gene (CCV) construct. (B) Protocols for deriving neurospheres from mouse ES cells. ES cells were
dissociated into single cells with 0.25% trypsin-EDTA and cultured for 6 days to allow the formation of embryoid bodies (EBs). A low concentration of
RA was added on day 2 of EB formation for neural induction. The EBs were dissociated into single cells with 0.25% trypsin-EDTA and cultured in
suspension for 7 days, to obtain primary neurospheres (ES cell-derived primary neurospheres, PNS). These PNS were dissociated into single cells with
TripleLE Select (Invitrogen) and cultured again in suspension for 7 days under the same conditions to form secondary neurospheres (SNS). (C) Images
of CCV-PNS and -SNS visualized by fluorescence microscopy. Scale bar: 100 mm. (D) Flow cytometric analysis of Venus-positive cells in PNS and SNS
derived from CCV- and EB3-ES cells. (E) The proportion of Venus-positive cells among CCV-ES cells and their progenies, CCV-PNS and -SNS.
Approximately 80% of the CCV-PNS and -SNS cells were positive for Venus. Values are means 6 s.e.m. (n=3). (F) Correlation between the cell
numbers of CCV-PNS and -SNS, and the measured photon counts. BLI revealed CBRluc expression in both CCV-PNS and -SNS, and we determined that
the photon counts were in direct proportion to the cell numbers in vitro. Values are means 6 s.e.m. (n=3). (G)(H) Distinct differentiation potentials of
PNS and SNS in vitro. Immunocytochemical analysis of bIII tubulin-positive neurons (N or n), GFAP-positive astrocytes (A or a), and O4-positive
oligodendrocytes (O or o) (N, A, O: more than 20 cells; n, a, o: fewer than 19 cells in each colony, respectively). A neuron-only colony (N) and a colony
consisting of astrocytes and oligodendrocytes (AO) are shown (G). Scale bar: 50 mm. Quantitative analysis of the in vitro differentiation potential of
EB3-PNS and -SNS and CCV-PNS and -SNS, shown as the percentage of each phenotypic colony among the total colonies (H). The PNS colonies
dominantly differentiated into neurons, while a small number of colonies contained glial cells. On the other hand, most of the SNS colonies
differentiated into both neurons and glial cells, including astrocytes and oligodendrocytes, or into only glial cells. Values are means 6 s.e.m. (n=3).
doi:10.1371/journal.pone.0007706.g001
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PLoS ONE | www.plosone.org 3 November 2009 | Volume 4 | Issue 11 | e7706Figure 2. Transplanted SNS prevented atrophic change and demyelination after SCI. (A)(B) Representative H–E staining images of the
sagittally sectioned (A1–3) and axially sectioned (B1–3) spinal cord at the lesion epicenter 6 weeks after injury. Scale bar: 500 mm. (C) Representative
LFB staining images of the axially sectioned spinal cord 1 mm caudal to the lesion from each animal (2 weeks or 6 weeks after SCI for the vehicle-
control group and 6 weeks after SCI for the PNS and SNS groups). Scale bar: 500 mm. (D) Higher magnification images of the boxed areas in C. Scale
bar: 100 mm. (E) Quantitative analysis of the spinal cord area measured in H–E-stained axial sections through different regions. The transverse area of
the spinal cord at the lesion epicenter was significantly larger in the SNS group compared with the control group. Values are means 6 s.e.m. (n=5).
*: P,0.05, Control vs. SNS. (F) Quantitative analysis of the myelinated area by LFB-stained axial sections at different regions. LFB staining revealed
greater preservation of myelination in the SNS group, with significant differences observed at the sites 1 mm rostral and 1 mm caudal to the
epicenter compared with the control 2 or 6 weeks groups, 1 mm caudal to the epicenter compared with the PNS group, and at the epicenter
compared with the control 2-week group. Values are means 6 s.e.m. (n=5). *: P,0.05, PNS vs. SNS. **: P,0.05, Control 6 weeks vs. SNS. ***: P,0.05,
Control 2 weeks vs. SNS.
doi:10.1371/journal.pone.0007706.g002
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after SCI
To examine the effects of CCV-PNS and -SNS transplantation
on angiogenesis after SCI, sagittal and axial sections of the injured
spinal cord were examined immunohistochemically for aSMA (a
marker for smooth muscle cells) or PECAM-1 (a marker for
endothelial cells). While a few aSMA-positive cells were observed
at and near the lesion site in sagittal sections of both the control
and PNS groups, significantly more aSMA-positive cells were
found in the SNS group (Fig. 5A and B). These aSMA-positive
cells accumulated near Venus-positive grafted cells (Fig. 5C and
D). Similarly, significantly more PECAM-1-positive blood vessels
were observed at the lesion site in the SNS group than in the PNS
and control groups (Fig. 5E–J, Y). To clarify the underlying
angiogenic signals, we examined the expression of an angiogenic
growth factor, vascular endothelial growth factor (VEGF), in the
grafted spinal cord by immunohistochemistry. Although a VEGF-
positive area was observed at the lesion epicenter in all three
groups 6 weeks after injury (Fig. 5K–M), it was significantly
broader in the SNS group than in the other groups (Fig. 5Z).
Furthermore, we found many GFAP/VEGF double-positive host
astrocytes, which were negative for Venus (GFP) (Fig. 5N–Q), and
a few Venus (GFP)/GFAP-positive graft-derived astrocytes
expressing VEGF (Fig. 5R–X).
Transplanted SNS, but Not PNS, Promoted Axonal
Regrowth and Enhanced Functional Recovery
To examine the effects of CCV-PNS and -SNS transplantation
on axonal regrowth after SCI, we performed immunohistochem-
ical analyses of the injured spinal cord for NF-H (RT97), 5-
hydroxytryptamine (5-HT), and growth-associated protein-43
(GAP43). While few NF-H-positive axons were observed at the
Figure 3. TransplantedPNS and SNS survived in the injuredspinal cord and did not form tumors. (A) Representative BLI images of mice
that received transplants of CCV-PNS and -SNS. (B) Signal intensity over time after transplantation in the PNS and SNS groups, shown relative to the
initial value. Although the signal intensity at 1 week after the injury was significantly higher in the PNS group (62.4%) than the SNS group (29.5%),
there was no significant difference in the signal intensity between the PNS (12.6%) and SNS (18.9%) groups 6 weeks after the injury. Values are
means 6 s.e.m. (n=11). *: P,0.05, PNS vs. SNS. Scale bar: 500 mm. (C)(D)(E)(F) Representative images of sagittal sections of spinal cords grafted with
PNS and SNS, which were immunostained for Venus (grafted cells) using an anti-GFP antibody. High-magnification images of the boxed areas in C
and E are shown in D and F. Scale bar: 500 mm for C and E, 100 mm for D and F. Histological analysis confirmed that both PNS- and SNS-derived cells
survived without forming tumors. (G) Quantitative analysis of Venus (GFP)-positive area at the lesion epicenter in midsagittal sections. Venus
immunostaining revealed there was no significant difference between PNS and SNS groups 6 weeks after transplantation Values are means 6 s.e.m.
(n=6). (H) Correlation of the results of BLI analysis and the quantification of Venus-positive area. The data of BLI correlated well with Venus-positive
area (n=12).
doi:10.1371/journal.pone.0007706.g003
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PLoS ONE | www.plosone.org 5 November 2009 | Volume 4 | Issue 11 | e7706Figure 4. In vivo differentiation characteristics of PNS and SNS grafted onto the injured spinal cord. (A)(B) Venus-positive PNS- and SNS-
derived grafted cells integrated at or near the lesion epicenter. Venus expression was detected by immunohistochemistry using an antibody against
GFP. Scale bar 100 mm. (C)(D)(E) Representative immunohistochemical images of Venus-positive grafted cells that were positive for markers of neural
lineages: Hu-positive neurons from PNS group (C), GFAP-positive astrocytes from SNS group (D), and APC-positive oligodendrocytes from SNS group
(E). Scale bar: 20 mm. (C-4, D-4, E-4) Higher-magnification image of the boxed areas in C-3, D-3, E-3. Scale bar: 20 mm. (F) The percentage of cell type-
specific marker positive cells among the Venus-positive grafted cells, showing the in vivo differentiation characteristics of PNS and SNS. The
percentage of Hu-positive neurons in the PNS group (52.8619.1%) was three times that in the SNS group (16.365.2%). In contrast, the percentage of
GFAP-positive astrocytes or APC-positive oligodendrocytes in the SNS group (42.2614.4, 33.665.4%) was twice that in the PNS group (19.069.3,
14.867.1%). Values are means 6 s.e.m. (n=4). *: P,0.05, PNS vs. SNS.
doi:10.1371/journal.pone.0007706.g004
ES Cell-Derived NS/PCs
PLoS ONE | www.plosone.org 6 November 2009 | Volume 4 | Issue 11 | e7706rim of the lesion epicenter in the control and PNS groups, there
were significantly more NF-H-positive neuronal fibers in the SNS
group at the lesion epicenter and perilesional area (Fig. 6A, B,
and E). 5-HT-positive serotonergic fibers, which are descending
raphespinal tract axons [16,17], were observed at the sites caudal
to the lesion epicenter in all three groups 6 weeks after injury
(Fig. 6C). Quantitative analysis revealed that there were
significantly more 5-HT-positive fibers at the site 4 mm caudal
to the lesion epicenter (Th10 level), which was approximately at
the L1 level, in the SNS group compared with the other groups
(Fig. 6F).
While few GAP43-positive axons [18,19,20] were detected
caudal to the lesion epicenter in the control and PNS groups, there
were significantly more GAP43-positive fibers in the SNS group in
the ventral region 1 mm caudal to the lesion epicenter (Fig. 6D,
G), suggesting that transplantation of the gliogenic SNS, but not of
the neurogenic PNS, promoted axonal regeneration in the injured
spinal cord.
We also observed NF-H-positive neuronal fibers extending along
with the GFAP-positive immature astrocytes, which may have been
partially derived from the grafted Venus-positive cells, and crossing
the perilesional area in the SNS group (Fig. 7Aa n dB ).
Furthermore, the SNS-derived Venus-positive cells differentiated
into MBP-positive oligodendrocytes, which myelinated NF-H-
positive fibers (Fig. 7C). Electron microscopy also revealed active
remyelination in the SNS group (Fig. 7D–F). The grafted cells were
insmall groups containing 50–100 cells (Fig. 7D). The axons at these
sites were enwrapped by myelin sheathes of various thicknesses and
numbers of lamellae, which were contributed by the grafted cells, as
confirmed by immunolabeling with an anti-GFP antibody to
distinguish the transplanted cells from the locally surviving recipient
cells (Fig. 7E). A much higher magnification revealed nanogold-
labeled Venus-positive spots in the outer and inner mesaxons of the
myelin cytoplasm. Some axons close to the lesion epicenter had
undergone considerable re-myelination, and were enwrapped in
spirals of more than ten layers of compacted lamellae (Fig. 7F).
Finally, we monitored the locomotor functional recovery in all
three groups using the BMS scoring scale [21]. The contusive SCI
resulted in complete paralysis (BMS score 0) on day 1, followed by
gradual recovery with a plateau around 3 weeks. Although there
was no significant difference in the BMS scores among the control,
PNS, and SNS groups on day 14, the SNS group exhibited
significantly better functional recovery than the PNS and control
groups on day 21 and thereafter. On the other hand, there was no
significant difference in the BMS scores between the PNS and
control groups (Fig. 7G). From a clinical perspective, the recovery
of the SNS group to levels exhibiting frequent to consistent weight-
supported plantar steps and occasional forelimb-hindlimb coordi-
nation was especially noteworthy.
Discussion
Methods for effectively inducing neural differentiation from
pluripotent ES cells have been extensively studied [6] and are
Figure 5. Transplanted SNS, but not PNS, enhanced angiogen-
esis after SCI. (A)(B)(C) Representative images of aSMA-immuno-
stained sections obtained from the control (A), PNS (B), and SNS (C)
groups. Scale bar: 500 mm. (D) Higher-magnification image of the area
indicated by the arrowhead in C. Scale bar: 20 mm. While a few aSMA-
positive Venus-expressing grafted cells were observed at and near the
lesion site in sagittal sections of both the control and PNS groups,
significantly more aSMA-positive cells were found in the SNS group,
with Venus-positive grafted cells accumulated near the aSMA-positive
cells, not colocalized with them. (E)(F)(G) Representative images of
PECAM-1-immunostained sections obtained from the Control (E), PNS
(F), and SNS (G) groups. Scale bar: 200 mm. (H)(I)(J) Higher-magnifica-
tion images of the boxed areas in E, F, and G. Scale bar: 100 mm.
(K)(L)(M) Representative images of axial sections stained for vascular
endothelial growth factor (VEGF). Scale bar: 100 mm. (N–X) Expression
of VEGF in GFAP-positive astrocytes among host-derived cells (N–Q)
and Venus-positive (GFP immunostained) graft-derived cells (R–X) in
the spinal cord from the SNS group (arrows indicate VEGF/GFAP
double-positive cells). SNS transplants promoted VEGF expression in
both the host- and graft-derived GFAP-positive astrocytes. Scale bar:
20 mm. (Y) Quantitative analysis of blood vessels at the lesion epicenter.
PECAM-1 immunostaining revealed similar results, with significantly
more PECAM-1-positive blood vessels observed at the lesion site in the
SNS group compared with the PNS and control groups. Values are
means 6 s.e.m. (n=3).*: P,0.05, Control vs. SNS. **: P,0.05, PNS vs.
SNS. (Z) Quantitative analysis of the VEGF-positive area at the lesion
epicenter. The VEGF-positive area at the lesion epicenter was
significantly broader in the SNS group than in the other groups. Values
are means 6 s.e.m. (n=3).*: P,0.05, Control vs. SNS. **: P,0.05, PNS vs.
SNS.
doi:10.1371/journal.pone.0007706.g005
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PLoS ONE | www.plosone.org 7 November 2009 | Volume 4 | Issue 11 | e7706Figure 6. Transplanted SNS, but not PNS, promoted axonal growth. (A) Representative images of sagittal sections stained for NF-H in all
three groups. Scale bar: 200 mm. (B) Representative images of axial sections stained for NF-H at the lesion epicenter in all three groups. Scale bar:
500 mm. (C) Representative images of axial sections stained for 5-HT 4 mm caudal to the epicenter from all three groups. Scale bar: 100 mm. (D)
Representative images of midsagittal sections stained for GAP43 in the ventral region 1 mm caudal to the epicenter from all three groups, and intact
spinal cord. Arrows: GAP43-positive fibers. Scale bar: 50 mm. (E) Quantitative analysis of the NF-H-positive area at each distance point. While few NF-H-
positive neuronal fibers were observed at the rim of the lesion epicenter in both the control and PNS groups, there were significantly more NF-H-
positive neuronal fibers in the SNS group (B-3) at the lesion epicenter, 1, 2, 3, 4 mm rostral and 3, 4 mm caudal to the lesion epicenter compared with
the control group (B-1), and at the lesion epicenter and 1, 2 mm rostral to the lesion site compared with the PNS group (B-2). Values are means 6
s.e.m. (n=5). *: P,0.05, Control vs. SNS. **: P,0.05, PNS vs. SNS. (F) Quantitative analysis of the 5-HT-positive area in axial sections 4 mm caudal to
the lesion epicenter. Significantly more 5-HT-positive fibers were observed in the SNS group compared with the other groups. Values are means 6
s.e.m. (n=3).*: P,0.05, Control (2 weeks after injury) vs. SNS. **: P,0.05, Control (6 weeks after injury) vs. SNS. ***: P,0.05, PNS vs. SNS. (G)
Quantitative analysis of the GAP43-positive area in midsagittal sections in the ventral region 1 mm caudal to the epicenter. Significantly more GAP43-
positive fibers were observed in the SNS group than in the other groups. Values are means 6 s.e.m. (n=4). *: P,0.05, Control vs. SNS. **: P,0.05, PNS
vs. SNS.
doi:10.1371/journal.pone.0007706.g006
ES Cell-Derived NS/PCs
PLoS ONE | www.plosone.org 8 November 2009 | Volume 4 | Issue 11 | e7706Figure 7. Transplanted SNS, but not PNS, promoted axonal growth, remyelination and functional recovery. (A) NF-H-positive neuronal
fibers were observed along with GFAP-positive immature astrocytes derived either from the Venus-positive grafts or the host, and crossed the
perilesional area in the SNS group. Scale bar: 50 mm. (B) Higher magnification images of the boxed area in A. Arrows: some examples of axons
associated with Venus (GFP)-positive astrocytes. (C) Immunohistochemical analysis of MBP and NF-H in the SNS-transplanted injured spinal cord. SNS-
derived Venus-positive cells differentiated into MBP-positive oligodendrocytes, which myelinated NF-H-positive fibers. Scale bar: 20 mm. (D)(E)(F)
Representative electron-microscopic images of a remyelination site in sagittal sections from injured spinal cords grafted with SNS, which were
immunostained for Venus (grafted cells) using an anti-GFP antibody. Low-magnification images show a group of grafted cells with active
remyelination (some indicated by open arrowheads) (D). High-magnification images from (E-1) to (E-12) were obtained from (D), and show various
numbers of lamellae in the myelin sheath. The remyelinating transplanted cells were detected as black dots (arrowheads). Venus (GFP)-positive dots
(arrows) were localized to the outer and inner mesaxons of the myelin cytoplasm (OM, IM) (F). My: Myelination, N: Nucleus, Scale bar: 5 mm for D,
200 nm for E and F. (G) Mean Basso Mouse Scale for Locomotion (BMS) scores for each group over the 49-day recovery period. Although there was no
significant difference in the BMS scores among the control, PNS, and SNS groups on day 14, the SNS group exhibited significantly better functional
recovery than the PNS and control groups on day 21 and thereafter. On the other hand, there was no significant difference in the BMS scores
between the PNS and control groups. Values are means 6 s.e.m. (n=11), *: P,0.05, SNS vs. control, 42 days after injury. **: SNS vs. PNS or SNS vs.
control on day 21, 28, 35, and 49 after injury.
doi:10.1371/journal.pone.0007706.g007
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However, detailed investigations of the optimal cell sources for
promoting recovery from SCI are lacking. We recently developed
an ES cell culture system that recapitulates the temporal
progression of NS/PCs from the FGF-responsive early neurogenic
NS/PCs to the EGF-responsive late gliogenic NS/PCs, consistent
with CNS development in vivo [10,23] (Fig. 1G, H). Taking
advantage of this difference in differentiation tendency, here we
examined the distinct effects of the neurogenic PNS and gliogenic
SNS on recovery following SCI.
One of the mechanisms underlying this developmental stage-
dependent gliogenic transition of NS/PCs is the epigenetic
regulation of glial cell-specific genes. The gradual demethylation
of CpGs around the Stat3 recognition sequence in the GFAP
promoter is thought to be involved in the developmental stage-
dependent increase in transcription of the GFAP gene and the
acquisition of astrocytic differentiation potentials [24,25,26].
Interestingly, this process is also observed in our ES cell-derived
neurosphere system, in which the proportion of unmethylated
CpGs in this region gradually increases during the development of
ES cells into secondary neurospheres [10]. This may explain why
the in vitro differentiation potentials of both the PNS and SNS were
preserved even after their transplantation into injured spinal cord,
despite its gliogenic environment (Fig. 4A–F) [27]. Since there was
no significant difference in the numbers of grafted PNS and SNS
in the injured spinal cord 6 weeks after transplantation, the
difference in the in vivo differentiation potentials of the grafted
neurospheres was the critical factor influencing the functional
recovery after SCI. More than 70% of the grafted SNS cells
differentiated into GFAP-positive astrocytes or APC-positive
oligodendrocytes, and the engraftment of these cells led to
improved functional recovery (Fig. 4F). In contrast, engrafted
PNS cells, which mainly differentiated into neurons, did not
promote functional recovery.
Determining the exact mechanisms through which the trans-
planted SNS, or glial cells, improved the recovery of the
traumatically injured CNS has been challenging. The engrafted
SNS cells could promote a wide range of effects, and here we
showed positive effects of their transplantation on tissue sparing,
myelination, angiogenesis, and axonal regeneration compared
with the control group, and on myelination, angiogenesis, and
axonal regeneration compared with the PNS group. One possible
explanation for the functional recovery observed in the SNS group
is that the SNS-derived astrocytes provided axonal guidance cues.
This idea is supported by previous studies in which glial
progenitors or glial progenitor-derived astrocytes were engrafted
[28,29,30,31]. Immature astrocytes purified from the postnatal
CNS have been shown to promote extensive neurite growth from
a variety of neurons [32,33].
Although the reactive astrocytes in glial scar tissue express
proteoglycans that can inhibit axonal growth, and have been
shown to play a major role in the formation of misaligned scar
tissue at sites of injury [34,35,36,37,38], we and others have
previously shown that reactive astrocytes also have pivotal roles in
the repair of injured tissue and recovery of motor function in the
subacute phase after SCI, by sealing off injured areas and
preventing the further spread of damage. They also produce an
array of neurotrophic and growth factors [39]. Moreover, some
astrocytes in the host spinal cord acquire stem-cell properties after
injury and hence represent a promising cell type for initiating
repair [40]. In combination with host astrocytes, immature
astrocytes generated by the grafted SNS may express axonal
growth-supporting molecules such as laminin, fibronectin, nerve
growth factor (NGF), neurotrophin-3 (NT-3), vasoactive intestinal
polypeptide (VIP), and activity-dependent neurotrophic factor
(ADNF) [41] with minimal expression of chondroitin sulfate
proteoglycans (CSPGs) [42]. In addition, SNS transplantation 9
days after SCI, between the acute and chronic phases, is likely to
prevent grafted cells from differentiating into glial scar-forming
reactive astrocytes due to their minimal expression of cytokines
[3,43] and instead generate immature astrocytes, which provide
cues for axonal regeneration. In fact, our immunohistochemical
analysis revealed NF-H-positive neuronal fibers aligned with
GFAP-positive fibers within the lesion site of the SNS group,
suggesting that the SNS transplants promoted the alignment of
regenerating axons with the fibers of astrocytes, which in turn
promoted axonal growth into and out of the SNS grafts (Fig. 7A
and B). In addition, the 5-HT-raphespinal system of the spinal
cord has been shown to represent axonal regeneration after spinal
cord injury [16,17], and the apparent regeneration and/or sparing
of host 5-HT-positive fibers elicited by the grafting of SNS may
have contributed to the observed functional recovery, since these
fibers were not observed in the control or PNS groups (Fig. 6C
and F).
Another possible explanation for the functional improvement in
the SNS group is the enhancement of angiogenesis, since
angiogenesis is reported to promote endogenous repair and
support axonal outgrowth after SCI [44]. Under hypoxic
conditions, astrocytes express angiogenic growth factors, including
VEGF [45,46]. We revealed that transplanted SNS, but not PNS,
enhanced angiogenesis after SCI (Fig. 5A–Z). We observed many
host astrocytes (Fig. 5N–Q), and a few SNS-graft-derived
astrocytes that expressed VEGF (Fig. 5R–X), suggesting that the
SNS transplants promoted VEGF expression in both the host- and
graft-derived GFAP-positive astrocytes. The increase in blood
vessels elicited by the transplantation of ES cell-derived gliogenic
NS/PCs may have improved axonal growth and prevented
atrophy of the injured spinal cord.
The functional improvement might also be due to remyelination
by SNS-derived oligodendrocytes, as supported by previous
transplantation studies of ES cell-derived NS/PCs or oligoden-
drocyte progenitor cells (OPCs) [8,47]. While the neurogenic PNS
dominantly differentiated into Hu-positive neurons (Fig. 4F), the
gliogenic SNS differentiated into APC-positive oligodendrocytes
that provided MBP-positive sheathes and promoted myelination
after SCI (Fig. 2C, D, F, and Fig.7C–F).
In summary, here we took advantage of our recently established
neurosphere-based culture system of ES cell-derived NS/PCs, in
which PNS and SNS exhibit neurogenic and gliogenic potentials,
respectively, and found that SNS cells were the most effective for
promoting recovery after SCI. We showed that grafted SNS
generated approximately equal numbers of GFAP-positive astro-
cytes and APC-positive oligodendrocytes in vivo. Both of these
glial cell types may have contributed to the functional recovery,
through trophic effects and the promotion of angiogenesis and
axonal regeneration by immature astrocytes, and possibly through
remyelination by grafted oligodendrocyte progenitor cells. Nota-
bly, the transplantation of PNS did not improve the functional
recovery after SCI. These findings provide critical information for
clinical trials using human ES- and induced pluripotent stem cell
(iPS)-derived NS/PC transplantation for SCI.
Moreover, our results suggest that ES cell-derived NS/PCs
cultured for relatively long periods may provide sufficient amounts
of efficient glial donor cells for cell transplantation therapies. This
strategy may also prevent the contamination of tumorigenic
undifferentiated ES cells that occurs during long-term culture
under serum-free conditions, and support the development of safe
embryonic stem cell-based treatment strategies for spinal cord
ES Cell-Derived NS/PCs
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Venus-positive cells survived without forming tumors for 6 weeks
after transplantation in this study, careful observation for a longer
period will be necessary to assess the possibility of tumor
formation.
In the near future, other types of pluripotent stem cells, such as
nuclear transfer ES (ntES) and iPS cells, which avoid the risk of
immunological rejection and ethical concerns, will need to be
evaluated to examine the applicability of human ES cells and
human iPS cells in clinical applications.
Materials and Methods
ES Cell Culture and Differentiation
Mouse ES cells (EB3) [13] grown on gelatin-coated (0.1%)
tissue-culture dishes were maintained in standard ES cell medium
and used for EB formation as previously described, with slight
modifications [9,13,48]. For neural induction, ES cells were
dissociated into single cells with 0.25% trypsin-EDTA and
cultured in bacteriological dishes for 6 days, to allow the formation
of EBs. A low concentration of RA (low-RA; 10
28 M, Sigma) was
added on day 2 of EB formation. The EBs were dissociated into
single cells with 0.25% trypsin-EDTA and cultured in suspension
at 5610
4 cells/ml for 7 days in Media hormone mix (MHM)
medium with 20 ng/ml FGF2 (Peprotech) and 2% B27 (Invitro-
gen), to obtain primary neurospheres (PNS). These PNS were
dissociated into single cells with TripleLE Select (Invitrogen) and
cultured again in suspension at 5610
4 cells/ml for 7 days under
the same conditions, to form secondary neurospheres (SNS)
(Fig. 1B) [10]. For differentiation analysis, PNS and SNS were
allowed to differentiate on poly-L-ornithine/fibronectin-coated
coverslips for 5 days, followed by immunocytochemistry. The
frequency of colonies consisting of bIII tubulin-positive neurons,
GFAP-positive astrocytes, and O4-positive oligodendrocytes (N, A,
O: colonies containing more than 20 positive cells are in capital
letters; n, a, o: colonies containing fewer than 19 cells are in lower-
case letters) is presented as the percentage of total colonies (50
colonies each) from three independent experiments.
Transfection of CAG-CBRluc-IRES-Venus
To visualize transplanted cells by both fluorescence and
luminescence, we established an ES cell line that constitutively
expresses a click beetle red-emitting luciferase variant (CBRluc)
[11] and Venus [a yellow fluorescence protein (YFP) mutant] [12]
by transfecting a linearized CAG-CBRluc-IRES-Venus plasmid
(CCV; Fig. 1A) into EB3 ES cells using lipofectamine2000
(Invitrogen). Stably transfected ES cells were selected by G418
(200 mg/ml), subcloned, and screened by the expression of both
CBRluc and Venus. The Venus could be detected by antibodies
against EGFP.
Flow Cytometry
Undifferentiated ES cells, PNS, and SNS were dissociated and
processed for flow cytometric analysis by FACS Calibur (Becton-
Dickinson). The Venus-positive cells were counted and are
presented as the percentage of the total number of cells, excluding
dead cells stained by propidium iodide.
Spinal Cord Injury Model and Transplantation
Adult female C57BL/6J mice (20–22 g) were anesthetized via
intraperitoneal (i.p.) injection of ketamine (100 mg/kg) and
xylazine (10 mg/kg). After laminectomy at the 10th thoracic
spinal vertebra (T10), a contusive SCI was induced at the same
level using a commercially available SCI device (IH impactor,
Precision Systems and Instrumentation, Lexington, KY), as
described previously [49]. This device creates a reliable contusion
injury by rapidly applying a force-defined impact (60 kdyn) with a
stainless steel-tipped impounder. The initial touch point of the
impactor with the dura was determined (using the vibrator mode
of the impactor tip), and from there a 1.5-mm displacement was
applied to the spinal cord. Force curve readings revealed an
average value of 6360.5 kdyn.
Nine days after the injury, CCV-PNS (n=11) or -SNS (n=11)
that had been cultured for 7 days were partially dissociated and
transplanted into the lesion epicenter using a glass micropipette
(5610
5 cells/mouse) and stereotaxic injector (KDS 310, Mur-
omachi-kikai, Tokyo, Japan). An equal volume of PBS was
injected into the control group (n=11). Hind limb motor function
was evaluated for 6 weeks after SCI using the locomotor rating test
of the Basso-Mouse-Scale (BMS), as described previously [21].
Well-trained investigators, blinded to the treatments, performed
the behavioral analysis, determining the BMS scores at the same
time each day. All animal experiments were approved by the
ethics committee of Keio University, and were in accordance with
the Guide for the Care and Use of Laboratory Animals (National
Institutes of Health, Bethesda, MD).
Bioluminescence Imaging (BLI)
BLI was performed using a Xenogen-IVIS 100 cooled CCD
optical macroscopic imaging system (SC BioScience, Tokyo,
Japan) [3,50]. To examine the effective expression of CBRluc in
vitro, we used a CCD-based macroscope detector to determine the
luminescence intensity of cultures with various numbers of cells (0
to 5610
5 cells per well) in the presence of D-luciferin (150 mg/ml).
The integration time was fixed at a 5-min duration for each image,
and the signals were reported as photons/cells/sec. For in vivo BLI,
D-luciferin was injected i.p. into mice (150 mg/kg body weight),
and serial images were acquired 15–40 min. later, until a
maximum signal intensity was obtained with the field-of-view,
which was set at 15 cm. We found this time window to be optimal,
since the signal intensity peaked 15–40 min after D-luciferin
administration, and was followed by a 15-min plateau (data not
shown). All images were analyzed with Igor (WaveMetrics, Lake
Oswego, OR) and Living Image software (Xenogen, Alameda,
CA), and the optical signal intensity was expressed as photon flux,
in units of photons/sec/cm
2/steradian. The results were displayed
as a pseudocolor photon count image superimposed on a grayscale
anatomic image. To quantify the measured light, we defined a
region of interest (ROI) over the cell-implanted area and
examined all the values within the same ROI. The signal intensity
of the engrafted cells was measured weekly for 6 weeks after
transplantation.
Histological Analyses
Animals were anesthetized and transcardially perfused with 4%
paraformaldehyde in 0.1 M PBS 6 weeks after transplantation.
The spinal cords were removed, embedded in OCT compound
(Sakura Finetechnical Co., Ltd.), and sectioned in the sagittal/
axial plane at 20 mm on a cryostat (Leica CM3050 S). The injured
spinal cords from the three groups were histologically evaluated by
Hematoxylin-eosin (H-E) staining, Luxol Fast Blue (LFB) staining,
and immunohistochemistry. The injured spinal cord from the
vehicle control group 2 weeks after SCI was also evaluated by LFB
staining and immunohistochemistry for 5-HT. Both cultured cells
and tissue sections were stained with the following primary
antibodies: anti-GFP (rabbit IgG, 1:500, MBL), anti-bIII tubulin
(mouse IgG, 1:1000, Sigma), Alexa488-conjugated anti-bIII
tubulin (mouse IgG, 1:4000, Covance), anti-Hu (human IgG,
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University), anti-GFAP (rabbit IgG, 1:4000, Dako), anti-GFAP
(guinea pig IgG, 1:4000, Advanced Immunochemical Inc.), anti-
GFAP (rat IgG, 1:200, Invitrogen), anti-O4 (mouse IgM, 1:5000,
Chemicon), anti-APC CC-1 (mouse IgG, 1:100, Calbiochem),
anti-MBP (chicken IgY, 1:200, Aves Labs), anti-Neurofilament
RT97 (NF-H, mouse IgG, 1:200, Chemicon), anti-5-HT (goat
IgG, 1:200, Immunostar), anti-GAP43 (mouse IgG, 1:2000,
Chemicon), Cy3-conjugated anti-SMA (mouse IgG 1:500, Sigma),
anti-PECAM-1 (rat IgG, 1:50, BD Bioscience Pharmingen), and
anti-VEGF (rabbit IgG, 1:50, Santa Cruz Biotechnology).
For immunohistochemistry with anti-Venus, VEGF, -NF-H, -5-
HT, and -GAP43 antibodies, we used a biotinylated secondary
antibody (Jackson Immunoresearch Laboratory, Inc.), after
exposure to 0.3% H2O2 for 30 minutes at room temperature to
inactivate endogenous peroxidase. The signals were enhanced
with the Vectastain ABC kit (Vector Laboratories, Inc.). Nuclei
were stained with Hoechst33258 (10 mg/ml, Sigma). The samples
were examined with a universal fluorescence microscope (Ax-
iocam, Carl Zeiss) or a confocal laser scanning microscope
(LSM510, Carl Zeiss).
For immunoelectron microscopy, frozen sections were incubat-
ed with nanogold-conjugated anti-rabbit secondary antibody
(1:100 Invitrogen) followed by incubation with the primary anti-
GFP antibody. After enhancement with HQ-Silver kit (Nanop-
robes Inc.), sections were postfixed with 0.5% osmium tetroxide,
dehydrated through ethanol, and embedded in Epon. Ultrathin
sections were stained with uranyl acetate and lead citrate, observed
under a transmission EM (JEOL model 1230), and photographed
with a Digital Micrograph 3.3 (Gatan Inc.).
Quantitative Analyses of Stained Tissue Sections through
Transplanted Spinal Cord
To quantify HE-, LFB-, or immunostained sections, images were
obtained by a universal fluorescence microscope (Axiocam, Carl
Zeiss), manually outlined, and quantified by Micro Computer
Imaging Device (MCID; Imaging Research Inc., St. Catharines,
Ontario, Canada). Constant threshold values were maintained for
all the analyses with MCID. HE-stained images were taken at the
lesion epicenter and 2, 1, and 0.5 mm rostral and caudal to the
epicenter in axial sections at 625 magnification (n=5, each). To
analyze the LFB-positive area after transplantation, we automati-
cally captured four regions from each animal in axial sections at the
lesion epicenter and 2 mm and 1 mm rostral and caudal to the
epicenter at6200 magnification. Analyses were performed 2 weeks
or 6 weeks after SCI for the vehicle-control group and 6 weeks after
for the PNS and SNS groups. The total myelinated area was
quantified by MCID using light intensity gain counting (n=3,
each). For the Venus (GFP)-positive area after transplantation, we
captured in midsagittal sections the epicenter at625 magnification
from each animal (6 weeks after SCI for the vehicle-control, PNS,
and SNS groups), and quantified the total Venus-positive area
(n=6, each). NF-H-stained images were taken at the epicenter and
4, 3, 2, 1, and 0.5 mm rostral and caudal to the epicenter in axial
sections at 650 magnification, and the NF-H-positive areas were
quantified using light intensity gain counting (n=5, each). VEGF-
stained images were taken at the lesion epicenter in axial sections at
650, and the VEGF-positive areas were quantified using light
intensity gain counting (n=3, each). To analyze the 5-HT-positive
area after transplantation, we automatically captured five regions
from each animal in axial sections 4-mm caudal to the lesion
epicenter (Th10 level), which was approximately at the L1 level, a
non-lesion site, at6200 magnification. The analysis was performed
2 weeks or 6 weeks after SCI for the vehicle-control group and 6
weeks after for the PNS and SNS groups. The total 5-HT-positive
area was quantified (n=3, for each condition). For the GAP43-
positive area after transplantation, we captured the ventral regions
in midsagittal sections 1 mm caudal to the epicenter at 6200
magnification from each animal (6 weeks after SCI for the vehicle-
control, PNS, and SNS groups), and quantified the total GAP43-
positive area (n=4). To quantify the proportion of cells positive for
each cell type-specific marker in vivo, we selected representative
midsagittal sections and automatically captured five regions within
500 mm rostral and caudal to the lesion epicenter at 6200. The
engrafted cells in each section that were positive for both Venus and
eachcelltype-specificmarker were counted (n=4).The PECAM-1-
positive blood vessels were counted manually in axial sections of the
lesion epicenter at 6200 magnification (n=3, each).
Statistical Analysis
All data are presented as the mean 6 s.e.m. An unpaired two-
tailed Student’s t-test was used for the BLI analyses and Venus-
stained analysis, and in vivo differentiation assays. ANOVA followed
bytheTurkey-Kramertestformultiplecomparisonsamongthethree
transplantation groups was used for the in vivo differentiation analysis
and PECAM-1-, VEGF-, 5HT-, and GAP43-stained analysis.
Repeated measures two-way ANOVA followed by the Turkey-
Kramer test was used for HE-, LFB-, NF-H-stained and BMS
analysis. Pearson’s correlation coefficient was used for correlation of
the results of BLI analysis and the quantification of Venus-positive
area. In all statistical analyses, the significance was set at P,0.05.
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